Condition
Capillary Malformations
Total Trials
2
Recruiting
0
Active
0
Completed
0
Key Insights
Highlights
Treatment Research
3 treatments under study, led by Intralesional Bleomycin Injection
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 80/100
Termination Rate
50.0%
1 terminated out of 2 trials
Success Rate
0.0%
-86.6% vs benchmark
Late-Stage Pipeline
50%
1 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
0
Data Visualizations
Phase Distribution
2Total
Phase 2 (1)
Phase 3 (1)
Trial Status
Terminated1
Unknown1
Clinical Trials (2)
Research Network
Common Treatments
- Intralesional Bleomycin Injection1
- Brimonidine1
- Electrosclerotherapy1
Active Sponsors
- Galderma R&D1
- The Hospital for Sick Children1
- IGEA1
- Sophie Horbach1
Top Investigators
The Hospital for Sick Children
Academic Medical Center (AMC)
Related Conditions
- Vascular Malformations1